The MicroRNA Market is witnessing robust adoption in oncology due to the ability of microRNAs to function as biomarkers for early cancer detection and prognosis. Specific microRNA signatures can indicate tumor presence, stage, and aggressiveness, aiding clinicians in personalized treatment planning. Therapeutic applications involve developing microRNA mimics or inhibitors to regulate gene...

The MicroRNA Market is segmented by products, applications, and end users. Consumables dominate product segments, including kits, reagents, and assay components for microRNA profiling. Instruments, such as sequencing and detection platforms, are integral to research and clinical applications. Applications are primarily in cancer diagnostics, cardiovascular diseases, and neurological disorders....